Featured Articles

1. Running A 697-Patient MS Study Through Crisis And Complexity 6/10/2025

   Review an ongoing Phase III open-label extension study evaluating the long-term safety and efficacy of ublituximab in patients with relapsing multiple sclerosis.

2. Boosting Recruitment Strategy For Phase III Study In Ulcerative Colitis 6/10/2025

   Learn about the successful execution of a challenging three-arm, randomized, placebo-controlled Phase 3 study in Ulcerative Colitis despite strict inclusion criteria and a limited patient pool.

3. Explore The 2024 Edition of Industry Pages™ — A Strategic Guide To Running Smarter, Faster, And Leaner Studies 6/10/2025

   This 2024 Industry Pages report provides an in-depth examination of the Central and Eastern European (CEE) clinical trial strategy, highlighting its pivotal role in global drug development.

4. Your Guide To Clinical Trials In Central and Eastern Europe 9/10/2024

   Explore this annual report that can assist decision-makers working to understand the clinical research market in Central and Eastern Europe.

5. How To Enroll 612 Patients In A Neurology Study On Time And Within Budget Despite Hurdles Caused By The Pandemic 7/23/2024

   Discover how a leading Indian pharmaceutical manufacturer and an Eastern European CRO successfully navigated the challenges of conducting clinical trials during the COVID-19 pandemic.

6. How To Boost Patient Recruitment In Rheumatology Using Digital Solutions 7/23/2024

   Patient enrollment is one of the biggest challenges for clinical trials in rheumatology. This article explains how to accelerate recruitment and ensure retention using digital solutions.

7. What Do Biostatisticians Think Of The ICH E9(R1) Addendum? 7/23/2024

   Gain insights from Kristina Bondareva, Head of Biostatistics at OCT Clinical, on the significance of the Addendum and the importance of adopting the estimand framework in clinical trials.

8. Data Management Solution For A Clinical-Stage Cancer Immunotherapy Study 7/23/2024

   Check out the results from a clinical first-in-human study evaluating the safety and tolerability of an investigational cancer immunotherapy in patients with advanced melanoma.

9. Preparing For The Next Pandemic: Lessons Learned 7/23/2024

   COVID-19 impacted how clinical trials are conducted and emphasized the need to stay ahead of emerging viruses and diseases. Explore insights on which measures and approaches will most likely continue to be implemented in the future.

10. Data Matters: Accelerating Dermatology Research With Precision! 7/23/2024

    When deadlines are tight, execution matters. Find out how Palleos delivered critical data packages, statistical analysis, and regulatory-ready documentation—on time and with precision!